tbio: the income statement

MyFinsight

For the quarter ending 2024-09-30, TBIO made $1,566K in revenue. -$7,257K in net income. Net profit margin of -463.41%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2024-09-30
Revenue from contract with customer, excluding assessed tax	1,566
Cost of revenue, total	557
Gross profit	1,009
Selling and marketing expense, total	880
Impairment charges	333
Research and development expense, total	2,174
General and administrative expense, total	3,099
Operating expenses	6,486
Operating income (loss)	-5,477
Interest and other income	78
Loss on extinguishment of notes payable	-491
Interest expense, includes related-party amounts of 169 for the three and nine months ended september 30, 2024 and 0 for the three and nine months ended september 30, 2023, respectively	219
Other (expense) income, net	-72
Nonoperating income (expense)	-704
Income (loss) from continuing operations before income taxes, noncontrolling interest	-6,181
Income tax expense (benefit), total	1
Income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest	-6,182
Net loss from discontinued operations	-460
Net loss	-6,642
Less redeemable convertible preferred stock dividends	615
Net income (loss) available to common stockholders, basic	-7,257

Basic eps	-4.09
Diluted eps	-4.09
Basic average shares	1,772,663
Diluted average shares	1,772,663